burinex leo comp bijsluiter viagra renova and dysplasia National Grandparents Day essay see url pomegranate acts like viagra follow koliko je stetan cialis reviews for 15 milligram abilify viagra lawsuit pfizer introduction background thesis about body fitness an essay see url write in spanish hamlet research paper on madness does bystolic cause sleepiness child psychology term paper topics https://switzerlanddanceschool.com/case/plan-dissertation-la-sparation-des-pouvoirs/8/ phd dissertation defense tips allegra x-14r manual cialis 2.5 mg opinioni watch follow url please do my essay for me follow link here scholarship essay university que hacer si viagra no funciona stephen klass viagra turkish viagra sweet click here dopo quanto fa effetto il cialis https://dianegottlieb.com/education/essay-topics-for-beginning-esl-students/93/ SĀPH™ technology is a self assembling peptidyl hydrogel, comprised of an amphiphilic, multidomain peptide (MDP) that serves as both a controlled, drug delivery platform, as well as a key basal component for new drug development. SĀPH™ preparations are designed using MDPs with alternating hydrophobic and hydrophilic amino acids, which under physiological conditions self-assemble into nanofibrous 3-dimensional macromolecular structures capable of incorporating dissimilar compounds for both rapid and sustained delivery options. MDP sequences can be further tailored to include moieties for promoting cell adhesion or used in conjunction with additional delivery products e.g., liposomes to provide multicomponent delivery systems.
SĀPH technology offers several advantages over current drug delivery products for generic drugs, including the delivery of small or large molecules (biologics, and drugs), minimizing side effects due to improved localization, and providing sustained delivery options without the need for repeated administration.
Peptides designed for SĀPH can also be covalently modified to exhibit unique bioactive elements (e.g, receptor binding or enzymatic activity domains), such that it forms the basis for new drug molecule development. Matrx is pursuing use of new SĀPH-derived drugs for several therapeutic areas including peripheral artery disease and diabetic retinopathy.